Vishuo Biomedical is a Singapore-based company that specializes in establishing a precision medicine platform for the diagnosis and treatment of various life-threatening diseases. With a team of dedicated IVD lab scientists, bioinformaticians, scientific curators, and software developers, Vishuo Biomedical offers a range of products and services to support clinical doctors in making informed decisions. Their product portfolio includes the iCMDB® knowledgebase, Origo™ precision oncology platform, and Clair™ PGx platform, which provides solutions for disease risk prediction, biomarker discovery, sequencing data analysis, and clinical diagnosis.

These products are powered by a robust relationship database, containing scientific mechanisms, clinical interpretations, and evidence from global databases and literature. Vishuo Biomedical's precision medicine platform enables healthcare professionals to streamline their workflow, with automated functions for QC, analysis, data visualization, and lab reporting. The integration of the iCMDB® knowledgebase allows for efficient population of clinical reports, while intelligent condition and molecular marker matching supports clinical trial matching.

Since 2012, Vishuo Biomedical's products and solutions have been successfully implemented in over 100 clinical diagnostic and research labs worldwide. Their vision is to bridge IVD big data and personalized medical care to improve patient outcomes and quality of life. With a commitment to precision, integrity, and accountability, Vishuo Biomedical strives to provide comprehensive and customized solutions for clinical genomics research at a competitive price